2230724-66-8
Chemical Structure
BTK inhibitor 8
- CAS No.: 2230724-66-8
- Formula:C24H23FN8O2
- Molecular Weight:474.49
IUPAC Name: 5-(tert-butyl)-N-(2-fluoro-4-(6-(1-methyl-1H-pyrazol-4-yl)-7H-pyrrolo[2,3-d]pyrimidin-4-yl)benzyl)-1,2,4-oxadiazole-3-carboxamide
InChIKey: XRNHJQXCSOAXLV-UHFFFAOYSA-N
SMILES: O=C(C1=NOC(C(C)(C)C)=N1)NCC2=CC=C(C3=C4C(NC(C5=CN(C)N=C5)=C4)=NC=N3)C=C2F
Biological Activity: BTK inhibitor 8 (Compound 27) is a Btk inhibitor with an IC50 of 0.11 nM. BTK inhibitor 8 inhibits Btk activity. BTK inhibitor 8 suppresses B cell activation. BTK inhibitor 8 is applicable to research related to arthritis and asthma[1].
| Cat. No. | Product Name | Purity | Description | Pricing | |||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
|
BTK inhibitor 8 | 99.96% | BTK inhibitor 8 (Compound 27) is a Btk inhibitor with an IC50 of 0.11 nM. BTK inhibitor 8 inhibits Btk activity. BTK inhibitor 8 suppresses B cell activation. BTK inhibitor 8 is applicable to research related to arthritis and asthma. | ||||||||||||||||||||
|
loading...
/
|
|||||||||||||||||||||||
Keywords
